Annual Current Liabilities
$18.18 M
+$11.05 M+155.15%
December 31, 2023
Summary
- As of February 10, 2025, RPHM annual total current liabilities is $18.18 million, with the most recent change of +$11.05 million (+155.15%) on December 31, 2023.
- During the last 3 years, RPHM annual current liabilities has risen by +$13.60 million (+296.88%).
Performance
RPHM Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
$1.35 M
-$1.47 M-52.10%
June 30, 2024
Summary
- As of February 10, 2025, RPHM quarterly total current liabilities is $1.35 million, with the most recent change of -$1.47 million (-52.10%) on June 30, 2024.
- Over the past year, RPHM quarterly current liabilities has dropped by -$16.83 million (-92.58%).
Performance
RPHM Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
RPHM Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +155.2% | -92.6% |
3 y3 years | +296.9% | -83.8% |
5 y5 years | +518.5% | -65.7% |
RPHM Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | -65.9% | -92.6% | at low |
5 y | 5-year | at high | -83.8% | -92.6% | at low |
alltime | all time | at high | -83.8% | -92.6% | at low |
Reneo Pharmaceuticals Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Jun 2024 | - | $1.35 M(-52.1%) |
Mar 2024 | - | $2.81 M(-84.5%) |
Dec 2023 | $18.18 M(+155.2%) | $18.18 M(+34.0%) |
Sep 2023 | - | $13.56 M(-1.3%) |
Jun 2023 | - | $13.74 M(+31.1%) |
Mar 2023 | - | $10.48 M(+47.1%) |
Dec 2022 | $7.12 M | $7.12 M(-24.6%) |
Sep 2022 | - | $9.45 M(+13.4%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $8.34 M(+5.4%) |
Mar 2022 | - | $7.91 M(+27.5%) |
Dec 2021 | $6.20 M(+35.4%) | $6.20 M(-2.4%) |
Sep 2021 | - | $6.35 M(+90.4%) |
Jun 2021 | - | $3.34 M(-15.1%) |
Mar 2021 | - | $3.93 M(-14.2%) |
Dec 2020 | $4.58 M(+55.8%) | - |
Dec 2020 | - | $4.58 M |
Dec 2019 | $2.94 M | - |
FAQ
- What is Reneo Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Reneo Pharmaceuticals?
- What is Reneo Pharmaceuticals annual current liabilities year-on-year change?
- What is Reneo Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Reneo Pharmaceuticals?
- What is Reneo Pharmaceuticals quarterly current liabilities year-on-year change?
What is Reneo Pharmaceuticals annual total current liabilities?
The current annual current liabilities of RPHM is $18.18 M
What is the all time high annual current liabilities for Reneo Pharmaceuticals?
Reneo Pharmaceuticals all-time high annual total current liabilities is $18.18 M
What is Reneo Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, RPHM annual total current liabilities has changed by +$11.05 M (+155.15%)
What is Reneo Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of RPHM is $1.35 M
What is the all time high quarterly current liabilities for Reneo Pharmaceuticals?
Reneo Pharmaceuticals all-time high quarterly total current liabilities is $18.18 M
What is Reneo Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, RPHM quarterly total current liabilities has changed by -$16.83 M (-92.58%)